 |
인쇄하기
취소
|
CJ Cheil Jedang, RaQualia join hands for acid pump antagonist
CJ Cheil Jedang said on September 3 that it has signed a licensing agreement with RaQualia Pharma Inc, a Japanese pharmaceutical venture, granting CJ exclusive rights to RaQualia’s acid pump Antagonists (RQ-00000004, RQ-00000774).
Under the terms of the agreement, CJ will have a marketing right in Korea and China to develop and commercialize RQ-00000004 and RQ-00000774.
In return, RaQual...
Under the terms of the agreement, CJ will have a marketing right in Korea and China to develop and commercialize RQ-00000004 and RQ-00000774.
In return, RaQual...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.